|
|
Phase II Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of H1, an adjuvanted TB subunit vaccine in HIV-infected, BCG-vaccinated Adults With CD4+ Lymphocyte Counts Greater Than 350 Cells/mm3
| Third-party funded project |
| Project title |
Phase II Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of H1, an adjuvanted TB subunit vaccine in HIV-infected, BCG-vaccinated Adults With CD4+ Lymphocyte Counts Greater Than 350 Cells/mm3 |
| Principal Investigator(s) |
Reither, Klaus
|
| Project Members |
Daubenberger, Claudia
|
| Organisation / Research unit |
Swiss Tropical and Public Health Institute (Swiss TPH) / Malaria Interventions (Lengeler) |
| Project start |
01.09.2010 |
| Probable end |
31.08.2012 |
| Status |
Completed |
| Abstract |
Abstract will follow |
| Financed by |
Commission of the European Union
|
| |
|
|
MCSS v5.8 PRO. 0.424 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
28/04/2024
Research Database / FORSCHUNGSDATENBANK
|
